BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23106895)

  • 1. Role of tumor necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor-inducible 14 (Fn14) axis in rheumatic diseases.
    Zhu LX; Zhang HH; Mei YF; Zhao YP; Zhang ZY
    Chin Med J (Engl); 2012 Nov; 125(21):3898-904. PubMed ID: 23106895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TWEAK and Fn14: new molecular targets for cancer therapy?
    Winkles JA; Tran NL; Berens ME
    Cancer Lett; 2006 Apr; 235(1):11-7. PubMed ID: 15885893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease.
    Burkly LC; Michaelson JS; Hahm K; Jakubowski A; Zheng TS
    Cytokine; 2007 Oct; 40(1):1-16. PubMed ID: 17981048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of TWEAK activity as a new treatment for inflammatory and degenerative diseases.
    Yepes M; Winkles JA
    Drug News Perspect; 2006 Dec; 19(10):589-95. PubMed ID: 17299600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-like weak inducer of apoptosis is a mitogen for liver progenitor cells.
    Tirnitz-Parker JE; Viebahn CS; Jakubowski A; Klopcic BR; Olynyk JK; Yeoh GC; Knight B
    Hepatology; 2010 Jul; 52(1):291-302. PubMed ID: 20578156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 protein (Fn14), in healthy tissues and in tissues affected by periodontitis.
    Kataria NG; Bartold PM; Dharmapatni AA; Atkins GJ; Holding CA; Haynes DR
    J Periodontal Res; 2010 Aug; 45(4):564-73. PubMed ID: 20546112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK.
    Chorianopoulos E; Heger T; Lutz M; Frank D; Bea F; Katus HA; Frey N
    Basic Res Cardiol; 2010 Mar; 105(2):301-13. PubMed ID: 19629561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.
    Dohi T; Borodovsky A; Wu P; Shearstone JR; Kawashima R; Runkel L; Rajman L; Dong X; Scott ML; Michaelson JS; Jakubowski A; Burkly LC
    Gastroenterology; 2009 Mar; 136(3):912-23. PubMed ID: 19109961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts.
    Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
    Clin Exp Immunol; 2006 Dec; 146(3):540-9. PubMed ID: 17100776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
    Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A
    Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the TWEAK/Fn14 pathway in autoimmune diseases.
    Xu WD; Zhao Y; Liu Y
    Immunol Res; 2016 Feb; 64(1):44-50. PubMed ID: 26659091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TWEAK as a target for therapy in systemic lupus erythematosus.
    Leng RX; Pan HF; Qin WZ; Wang C; Chen LL; Tao JH; Ye DQ
    Mol Biol Rep; 2011 Jan; 38(1):587-92. PubMed ID: 20358293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TWEAK/Fn14 activation induces keratinocyte proliferation under psoriatic inflammation.
    Cheng H; Xu M; Liu X; Zou X; Zhan N; Xia Y
    Exp Dermatol; 2016 Jan; 25(1):32-7. PubMed ID: 26264384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A further TWEAK to multiple sclerosis pathophysiology.
    Nazeri A; Heydarpour P; Sadaghiani S; Sahraian MA; Burkly LC; Bar-Or A
    Mol Neurobiol; 2014 Feb; 49(1):78-87. PubMed ID: 23873135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of cytokine TWEAK and its receptor Fn14 in pig (Sus scrofa).
    Shui Y; Guan ZB; Zhang SQ
    Vet Immunol Immunopathol; 2008 Dec; 126(3-4):396-402. PubMed ID: 18817982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TWEAK promotes the production of Interleukin-17 in rheumatoid arthritis.
    Park JS; Park MK; Lee SY; Oh HJ; Lim MA; Cho WT; Kim EK; Ju JH; Park YW; Park SH; Cho ML; Kim HY
    Cytokine; 2012 Oct; 60(1):143-9. PubMed ID: 22819243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of TNF-induced IL-6 by the TWEAK-Fn14 interaction in rheumatoid arthritis fibroblast like synoviocytes.
    Yamana J; Morand EF; Manabu T; Sunahori K; Takasugi K; Makino H; Yamamura M
    Cell Immunol; 2012; 272(2):293-8. PubMed ID: 22055894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of TWEAK/Fn14 in neuroblastoma: implications in tumorigenesis.
    Pettersen I; Baryawno N; Abel F; Bakkelund WH; Zykova SN; Winberg JO; Moens U; Rasmuson A; Kogner P; Johnsen JI; Sveinbjörnsson B
    Int J Oncol; 2013 Apr; 42(4):1239-48. PubMed ID: 23443741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological activation of canonical nuclear-factor κB by synergy of tumor necrosis factor α and TNF-like weak inducer of apoptosis in mouse acute colitis.
    Dohi T; Kawashima R; Kawamura YI; Otsubo T; Hagiwara T; Amatucci A; Michaelson J; Burkly LC
    Cytokine; 2014 Sep; 69(1):14-21. PubMed ID: 25022957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA.
    Kamijo S; Nakajima A; Kamata K; Kurosawa H; Yagita H; Okumura K
    Rheumatology (Oxford); 2008 Apr; 47(4):442-50. PubMed ID: 18310134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.